Physician profile
Sungkoo Jang
NPI 1578699294
$265,351.78
in general payments reported to CMS, 2019-2025
4 companies · $34K in 2025
The $34K reported for 2025 was more than what 98% of Prosthodontics providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68K · 2020: $39K · 2021: $25K · 2022: $35K · 2023: $50K · 2024: $13K · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $98K · Food and Beverage: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $97,600.00 |
| Food and Beverage | $166.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hiossen, INC. | $265,000.00 | 2019-2025 | |
| Align Technology, INC. | $185.20 | 2020-2021 | |
| Nobel Biocare USA | $141.18 | 2023 | Nobelactive |
| Carestream Dental, LLC | $25.40 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sungkoo Jang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.